USANA Health Sciences (NYSE:USNA) Sets New 1-Year Low – Here’s Why

USANA Health Sciences, Inc. (NYSE:USNA) shares reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $34.08 and last traded at $34.08, with a volume of 22108 shares traded. The stock had previously closed at $34.71.

Wall Street Analyst Weigh In

USNA has been the topic of a number of recent analyst reports. DA Davidson upgraded USANA Health Sciences to a “hold” rating in a research report on Friday. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Thursday.

USANA Health Sciences Stock Performance

The company has a market capitalization of $636.22 million, a P/E ratio of 11.80, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. The firm’s fifty day moving average is $37.91 and its 200-day moving average is $40.37.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the previous year, the company posted $0.59 EPS. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Insider Transactions at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Pzena Investment Management LLC raised its holdings in USANA Health Sciences by 7.5% during the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after purchasing an additional 72,977 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of USANA Health Sciences by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock worth $30,907,000 after buying an additional 3,889 shares during the period. Pacer Advisors Inc. raised its stake in USANA Health Sciences by 16.5% during the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after buying an additional 76,904 shares during the last quarter. State Street Corp lifted its holdings in USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock valued at $16,501,000 after buying an additional 2,782 shares during the period. Finally, Geode Capital Management LLC boosted its position in USANA Health Sciences by 4.5% during the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after acquiring an additional 12,898 shares during the last quarter. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.